These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10862349)

  • 1. [The participation of the transport-barrier functions of the plasma membrane in the development of fluoroquinolone (ciprofloxacin) resistance in Acholeplasma laidlawii].
    Abramycheva NIu; Govorun VM
    Antibiot Khimioter; 2000; 45(5):14-9. PubMed ID: 10862349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in Acholeplasma laidlawii plasma membrane functions during development of resistance to ciprofloxacin and tetracycline].
    Abramycheva NIu; Potapova AA; Govorun VM
    Antibiot Khimioter; 2001; 46(3):12-5. PubMed ID: 11548275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glucose transport into membrane vesicles from Acholeplasma laidlawii cells].
    Panchenko LF; Fedotov NS; Goriacheva LA; Tarshis MA
    Dokl Akad Nauk SSSR; 1975; 221(2):487-9. PubMed ID: 235409
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.
    Giraud E; Cloeckaert A; Kerboeuf D; Chaslus-Dancla E
    Antimicrob Agents Chemother; 2000 May; 44(5):1223-8. PubMed ID: 10770755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the properties of the plasma membrane of Acholeplasma laidlawii under the action of tetracycline].
    Abramycheva NIu; Vakhrusheva TV; Govorun VM
    Antibiot Khimioter; 1999; 44(2):8-12. PubMed ID: 10202551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The appearance of ciprofloxacin resistance in the microbial strains isolated from gynecologic patients].
    Shopova E
    Akush Ginekol (Sofiia); 1997; 36(1):14-6. PubMed ID: 9289951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.
    Raherison S; Gonzalez P; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Mar; 46(3):672-9. PubMed ID: 11850247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation to Antimicrobials and Pathogenicity in Mycoplasmas: Development of Ciprofloxacin-Resistance and Evolution of Virulence in Acholeplasma laidlawii.
    Medvedeva ES; Mouzykantov AA; Kostenko VV; Baranova NB; Markelova MI; Sabouni RG; Khusnutdinova DR; Chernova OA; Chernov VM
    Dokl Biochem Biophys; 2021 Nov; 501(1):444-448. PubMed ID: 34966969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF.
    Pumbwe L; Randall LP; Woodward MJ; Piddock LJ
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1289-93. PubMed ID: 15793099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of mycoplasmas to antimicrobial agents: Acholeplasma laidlawii extracellular vesicles mediate the export of ciprofloxacin and a mutant gene related to the antibiotic target.
    Medvedeva ES; Baranova NB; Mouzykantov AA; Grigorieva TY; Davydova MN; Trushin MV; Chernova OA; Chernov VM
    ScientificWorldJournal; 2014; 2014():150615. PubMed ID: 24605048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Formation of M. hominis and A. laidlawii resistance to fluoroquinolones].
    Govorun VM; Gushchin AE; Ladygina VG; Abramycheva NIu; Topol' IuIu
    Mol Gen Mikrobiol Virusol; 1998; (3):16-9. PubMed ID: 9819821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of mutations in the A-subunit of Acholeplasma laidlawii PG-8B topoisomerase IV in formation of resistance to fluoroquinolones].
    Taganov KD; Gushchin AE; Abramycheva NIu; Govorun VM
    Mol Gen Mikrobiol Virusol; 2000; (2):30-3. PubMed ID: 10876765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3-O-methl-D-glucose transport system in the cells of Acholeplasma laidlawii].
    Bekkuzhin AG; Panchenko LF; Tarshis MA
    Vopr Med Khim; 1976; 22(2):212-5. PubMed ID: 1025884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some biochemical properties of Acholeplasma laidlawii mutants defective in glucose carrier].
    Ladygina VG; Migushina VL; Abaeva TP; Logachev AP; Tarshis MA
    Biokhimiia; 1977 Jan; 42(1):151-8. PubMed ID: 851551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol in mycoplasma membranes. I. Kinetics and equilibrium studies of cholesterol uptake by the cell membrane of Acholeplasma laidlawii.
    Gershfeld NL; Wormser M; Razin S
    Biochim Biophys Acta; 1974 Jun; 352(3):371-84. PubMed ID: 4841672
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine.
    Markham PN
    Antimicrob Agents Chemother; 1999 Apr; 43(4):988-9. PubMed ID: 10103220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.
    Mazzariol A; Tokue Y; Kanegawa TM; Cornaglia G; Nikaido H
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3441-3. PubMed ID: 11083655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the plasma membrane of Mycoplasma laidlawii. 8. Effect of temperature shift and antimetabolites on K + transport.
    Cho HW; Morowitz HJ
    Biochim Biophys Acta; 1972 Jul; 274(1):105-10. PubMed ID: 5044055
    [No Abstract]   [Full Text] [Related]  

  • 20. Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus.
    Khan IA; Mirza ZM; Kumar A; Verma V; Qazi GN
    Antimicrob Agents Chemother; 2006 Feb; 50(2):810-2. PubMed ID: 16436753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.